1. Xu Y, You J, Yao J, Hou B, Wang W, Hao Z. Klotho alleviates oxidative stress and mitochondrial dysfunction through the Nrf2/HO-1 pathway, thereby reducing renal senescence induced by calcium oxalate crystals. Urolithiasis. 2025 Mar 29;53(1):61. doi: 10.1007/s00240-025-01734-z. PMID: 40156629.
2. Castellaro AM, Tonda A, Cejas HH, Ferreyra H, Caputto BL, Pucci OA, Gil GA. Oxalate induces breast cancer. BMC Cancer. 2015 Oct 22;15:761. doi: 10.1186/s12885-015-1747-2. PMID: 26493452; PMCID: PMC4618885.
3. Chaiyarit S, Thongboonkerd V. Mitochondrial Dysfunction and Kidney Stone Disease. Front Physiol. 2020 Oct 20;11:566506. doi: 10.3389/fphys.2020.566506. PMID: 33192563; PMCID: PMC7606861.
4. Waikar SS, Srivastava A, Palsson R, Shafi T, Hsu CY, Sharma K, Lash JP, Chen J, He J, Lieske J, Xie D, Zhang X, Feldman HI, Curhan GC; Chronic Renal Insufficiency Cohort study investigators. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. JAMA Intern Med. 2019 Apr 1;179(4):542-551. doi: 10.1001/jamainternmed.2018.7980. PMID: 30830167; PMCID: PMC6450310.
5. Baltazar, P.; de Melo Junior, A.F.; Fonseca, N.M.; Lança, M.B.; Faria, A.; Sequeira, C.O.; Teixeira-Santos, L.; Monteiro, E.C.; Campos Pinheiro, L.; Calado, J.; et al. Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity. Genes 2023, 14, 1719. https://doi.org/10.3390/genes14091719
6. Hawkins-van der Cingel G, Walsh SB, Eckardt KU, Knauf F. Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease. Mayo Clin Proc. 2024 Jul;99(7):1149-1161. doi: 10.1016/j.mayocp.2024.02.006. Epub 2024 May 17. PMID: 38762815.
7. Liu J, Liu X, Guo L, Liu X, Gao Q, Wang E, Dong Z. PPARγ agonist alleviates calcium oxalate nephrolithiasis by regulating mitochondrial dynamics in renal tubular epithelial cell. PLoS One. 2024 Sep 26;19(9):e0310947. doi: 10.1371/journal.pone.0310947. PMID: 39325731; PMCID: PMC11426502.
8. Puurunen M, Kurtz C, Wheeler A, Mulder K, Wood K, Swenson A, Curhan G. Twenty-four-hour urine oxalate and risk of chronic kidney disease. Nephrol Dial Transplant. 2024 Apr 26;39(5):788-794. doi: 10.1093/ndt/gfad221. PMID: 37804181; PMCID: PMC11873791.
9. Wu L, Xue X, He C, Lai Y, Tong L. Cell death‑related molecules and targets in the progression of urolithiasis (Review). Int J Mol Med. 2024 Jun;53(6):52. doi: 10.3892/ijmm.2024.5376. Epub 2024 Apr 26. PMID: 38666544; PMCID: PMC11090264.
10. Kumar P, Patel M, Oster RA, Yarlagadda V, Ambrosetti A, Assimos DG, Mitchell T. Dietary Oxalate Loading Impacts Monocyte Metabolism and Inflammatory Signaling in Humans. Front Immunol. 2021 Feb 25;12:617508. doi: 10.3389/fimmu.2021.617508. PMID: 33732242; PMCID: PMC7959803.
11. Kumar P, Laurence E, Crossman DK, Assimos DG, Murphy MP, Mitchell T. Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen species (ROS) signaling. Redox Biol. 2023 Nov;67:102919. doi: 10.1016/j.redox.2023.102919. Epub 2023 Oct 4. PMID: 37806112; PMCID: PMC10565874.
12. Nishizawa, Y., Miyata, S., Tosaka, M. et al. Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients. Sci Rep 13, 18558 (2023). https://doi.org/10.1038/s41598-023-45903-9
13. Zeng, Z., Xu, S., Wang, F. et al. HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps. Oncogene 41, 3719–3731 (2022). https://doi.org/10.1038/s41388-022-02248-3
14. Prochaska ML, Moe OW, Asplin JR, Coe FL, Worcester EM. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 Jul;9(13):e14943. doi: 10.14814/phy2.14943. PMID: 34231328; PMCID: PMC9814525.
15. Trbojevic-Stankovic, J. (2022, November). Oxalate handling in health and disease—Crosstalk gut and kidney. NEP Newsletter.
16. Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, Holmes RP. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413. doi: 10.1152/ajprenal.00373.2018. Epub 2018 Dec 19. PMID: 30566003; PMCID: PMC6459305.
17. Stepanova N. Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives. Biomedicines. 2023 Jun 7;11(6):1654. doi: 10.3390/biomedicines11061654. PMID: 37371749; PMCID: PMC10296321.
18. Bargagli M, Tio MC, Waikar SS, Ferraro PM. Dietary Oxalate Intake and Kidney Outcomes. Nutrients. 2020 Sep 2;12(9):2673. doi: 10.3390/nu12092673. PMID: 32887293; PMCID: PMC7551439.
19. Chen T, Qian B, Zou J, Luo P, Zou J, Li W, Chen Q, Zheng L. Oxalate as a potent promoter of kidney stone formation. Front Med (Lausanne). 2023 Jun 5;10:1159616. doi: 10.3389/fmed.2023.1159616. PMID: 37342493; PMCID: PMC10278359.
20. Febriana L. et al. A review on the pharmacotherapy and case studies of hypercalciuria and hyperoxaluria. Journal of Applied Pharmaceutical Science, 2022.